Predicting the risk of active pulmonary tuberculosis in people living with HIV: development and validation of a nomogram

被引:9
作者
Chen, Jinou [1 ]
Li, Ling [2 ]
Chen, Tao [1 ]
Yang, Xing [1 ]
Ru, Haohao [1 ]
Li, Xia [3 ]
Yang, Xinping [3 ]
Xie, Qi [3 ]
Xu, Lin [1 ]
机构
[1] Yunnan Ctr Dis Control & Prevent, Div OfTB Control & Prevent, Kunming, Yunnan, Peoples R China
[2] Family Hlth Int Off, Kunming, Yunnan, Peoples R China
[3] Yunnan Prov Hosp Infect Dis, Kunming, Yunnan, Peoples R China
关键词
Tuberculosis; HIV; Nomogram; INFECTION; DIAGNOSIS; SELECTION; MODEL;
D O I
10.1186/s12879-022-07368-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Diagnosis of pulmonary tuberculosis (PTB) among people living with HIV (PLHIV) was challenging. The study aimed to develop and validated a simple, convenient screening model for prioritizing TB among PLHIV. Methods The study included eligible adult PLHIV participants who attended health care in Yunnan, China, from January 2016 to July 2019. Participants included before June 2018 were in the primary set; others were in the independent validation set. The research applied the least absolute shrinkage and selection operator regression to identify predictors associated with bacteriological confirmed PTB. The TB nomogram was developed by multivariate logistic regression. The C-index, receiver operating characteristic curve (ROC), the Hosmer-Lemeshow goodness of fit test (H-L), and the calibration curves were applied to evaluate and calibrate the nomogram. The developed nomogram was validated in the validation set. The clinical usefulness was assessed by cutoff analysis and decision curve analysis in the primary set. Result The study enrolled 766 PLHIV, of which 507 were in the primary set and 259 in the validation set, 21.5% and 14.3% individuals were confirmed PTB in two sets, respectively. The final nomogram included 5 predictors: current CD 4 cell count, the number of WHO screen tool, previous TB history, pulmonary cavity, and smoking status (p < 0.05). The C-statistic was 0.72 (95% CI 0.66-0.77) in primary set and 0.68 (95% CI 0.58-0.75) in validation set, ROC performed better than other models. The nomogram calibration was good (H-L chi(2) = 8.14, p = 0.15). The area under the decision curve (0.025) outperformed the existing models. The optimal cutoff for screening TB among PLHIV was the score of 100 (sensitivity = 0.93, specificity = 0.35). Conclusion The study developed and validated a discriminative TB nomogram among PLHIV in the moderate prevalence of TB and HIV. The easy-to-use and straightforward nomogram would be beneficial for clinical practice and rapid risk screening in resource-limited settings.
引用
收藏
页数:12
相关论文
共 43 条
  • [1] Discrimination and Calibration of Clinical Prediction Models Users' Guides to the Medical Literature
    Alba, Ana Carolina
    Agoritsas, Thomas
    Walsh, Michael
    Hanna, Steven
    Iorio, Alfonso
    Devereaux, P. J.
    McGinn, Thomas
    Guyatt, Gordon
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (14): : 1377 - 1384
  • [2] A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers
    Balcha, T. T.
    Skogmar, S.
    Sturegard, E.
    Schon, T.
    Wingvist, N.
    Reepalu, A.
    Jema, Z. H.
    Tibesso, G.
    Bjork, J.
    Bjorkman, P.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (03):
  • [3] Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults
    Blanc, Francois-Xavier
    Badje, Anani D.
    Bonnet, Maryline
    Gabillard, Delphine
    Messou, Eugene
    Muzoora, Conrad
    Samreth, Sovannarith
    Nguyen, Bang D.
    Borand, Laurence
    Domergue, Anais
    Rapoud, Delphine
    Natukunda, Naome
    Thai, Sopheak
    Juchet, Sylvain
    Eholie, Serge P.
    Lawn, Stephen D.
    Domoua, Serge K.
    Anglaret, Xavier
    Laureillard, Didier
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) : 2397 - 2410
  • [4] Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
    Boehme, Catharina C.
    Nabeta, Pamela
    Hillemann, Doris
    Nicol, Mark P.
    Shenai, Shubhada
    Krapp, Fiorella
    Allen, Jenny
    Tahirli, Rasim
    Blakemore, Robert
    Rustomjee, Roxana
    Milovic, Ana
    Jones, Martin
    O'Brien, Sean M.
    Persing, David H.
    Ruesch-Gerdes, Sabine
    Gotuzzo, Eduardo
    Rodrigues, Camilla
    Alland, David
    Perkins, Mark D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) : 1005 - 1015
  • [5] A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV
    Boyles, Tom H.
    Nduna, Matilda
    Pitsi, Thalitha
    Scott, Lesley
    Fox, Matthew P.
    Maartens, Gary
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (02):
  • [6] Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
    Chang, Charlotte A.
    Meloni, Seema Thakore
    Eisen, Geoffrey
    Chaplin, Beth
    Akande, Patrick
    Okonkwo, Prosper
    Rawizza, Holly E.
    Tchetgen, Eric Tchetgen
    Kanki, Phyllis J.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (04): : 1 - 11
  • [7] Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1038/bjc.2014.639, 10.1002/bjs.9736, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.7326/M14-0698]
  • [8] Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status
    Corbett, Elizabeth L.
    Zezai, Abbas
    Cheung, Yin Bun
    Bandason, Tsitsi
    Dauya, Ethel
    Munyati, Shungu S.
    Butterworth, Anthony E.
    Rusikaniko, Simba
    Churchyard, Gavin J.
    Mungofa, Stanley
    Hayes, Richard J.
    Mason, Peter R.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2010, 88 (01) : 13 - 21
  • [9] Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis
    Dhana, Ashar
    Hamada, Yohhei
    Kengne, Andre P.
    Kerkhoff, Andrew D.
    Rangaka, Molebogeng X.
    Kredo, Tamara
    Baddeley, Annabel
    Miller, Cecily
    Singh, Satvinder
    Hanifa, Yasmeen
    Grant, Alison D.
    Fielding, Katherine
    Affolabi, Dissou
    Merle, Corinne S.
    Wachinou, Ablo Prudence
    Yoon, Christina
    Cattamanchi, Adithya
    Hoffmann, Christopher J.
    Martinson, Neil
    Mbu, Eyongetah Tabenyang
    Sander, Melissa S.
    Balcha, Taye T.
    Skogmar, Sten
    Reeve, Byron W. P.
    Theron, Grant
    Ndlangalavu, Gcobisa
    Modi, Surbhi
    Cavanaugh, Joseph
    Swindells, Susan
    Chaisson, Richard E.
    Khan, Faiz Ahmad
    Howard, Andrea A.
    Wood, Robin
    Thit, Swe Swe
    Kyi, Mar Mar
    Hanson, Josh
    Drain, Paul K.
    Shapiro, Adrienne E.
    Kufa, Tendesayi
    Churchyard, Gavin
    Nguyen, Duc T.
    Graviss, Edward A.
    Bjerrum, Stephanie
    Johansen, Isik S.
    Gersh, Jill K.
    Horne, David J.
    LaCourse, Sylvia M.
    Al-Darraji, Haider Abdulrazzaq Abed
    Kamarulzaman, Adeeba
    Kempker, Russell R.
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (04) : 507 - 518
  • [10] World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
    Di Angelantonio, Emanuele
    Kaptoge, Stephen
    Pennells, Lisa
    De Bacquer, Dirk
    Cooney, Marie Therese
    Kavousi, Maryam
    Stevens, Gretchen
    Riley, Leanne
    Savin, Stefan
    Altay, Servet
    Amouyel, Philippe
    Assmann, Gerd
    Bell, Steven
    Ben-Shlomo, Yoav
    Berkman, Lisa
    Beulens, Joline W.
    Bjorkelund, Cecilia
    Blaha, Michael J.
    Blazer, Dan G.
    Bolton, Thomas
    Bonita, Ruth
    Brenner, Beaglehole Hermann
    Brunner, Eric J.
    Casiglia, Edoardo
    Chamnan, Parinya
    Choi, Yeun-Hyang
    Chowdhury, Rajiv
    Coady, Sean
    Crespo, Carlos J.
    Cushman, Mary
    Dagenais, Gilles R.
    D'Agostino, Ralph B.
    Daimon, Makoto
    Davidson, Karina W.
    Engstrom, Gunnar
    Fang, Xianghua
    Ford, Ian
    Gallacher, John
    Gansevoort, Ron T.
    Gaziano, Thomas Andrew
    Giampaoli, Simona
    Grandits, Greg
    Grimsgaard, Sameline
    Grobbee, Diederick E.
    Gudnason, Vilmundur
    Guo, Qi
    Humphries, Steve
    Iso, Hiroyasu
    Jukema, J. Wouter
    Kauhanen, Jussi
    [J]. LANCET GLOBAL HEALTH, 2019, 7 (10): : E1332 - E1345